1
2
1
API | Produktname | CAS-NR. | Einstufung |
Sotagliflozin | 4-Iod-1-chlor-2-(4-ethoxybenzyl)benzol | 1103738-29-9 | Diabetes |
Sotagliflozin | D-Xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethyliden)-1-C-4-Morpholinyl-,(5S)- | 1103738-19-7 | Diabetes |
Sotagliflozin | D-Xylo-Pentodialdo-5,2-furanose, 1-C-[4-Chlor-3-[(4-ethoxyphenyl)Methyl]phenyl]-4,5-O-(1-Methylethyliden)-,(5S) - | 1103738-30-2 | Diabetes |
Sotagliflozin | 5-Brom-2-chlor-4'-ethoxydiphenylmethan | 461432-23-5 | Diabetes |
Canagliflozin | 2-(4-FLUOROPHENYL)THIOPHEN | 58861-48-6 | Diabetes |
Canagliflozin | 5-Brom-2-methylbenzoesäure | 79669-49-1 | Diabetes |
Canagliflozin | 2-(4-Fluorphenyl)-5-[(5-Iod-2-methylphenyl)methyl]thiophen | 898566-17-1 | Diabetes |
Empagliflozin | (3S)-3-[4-[(5-Brom-2-chlorphenyl)methyl]phenoxy]tetrahydrofuran | 915095-89-5 | Diabetes |
Linagliptin | 8-Brom-7-(but-2-inyl)-3-methyl-1H-purin-2,6(3H,7H)-dion | 666816-98-4 | Diabetes |
Linagliptin | 2-(Chlormethyl)-4-methylchinazolin | 109113-72-6 | Diabetes |
Linagliptin | 8-Brom-7-but-2-inyl-3-methyl-1-(4-methyl-chinazolin-2-ylmethyl)-3,7-dihydro-purin-2,6-dion | 853029-57-9 | Diabetes |
Saxagliptin | (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexan-2-carbonsäure-tert-butylester | 361440-67-7 | Diabetes |
Saxagliptin | (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decan-1-essigsäure | 361442-00-4 | Diabetes |
Sitagliptin | 2,4,5-Trifluorphenylessigsäure | 209995-38-0 | Diabetes |
Sitagliptin | Boc-(R)-3-Amino-4-(2,4,5-Trifluor-phenyl)-buttersäure | 486460-00-8 | Diabetes |
2
API | Produktname | CAS-NR. | Einstufung |
Sitagliptin | 3-(Trifluormethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazinhydrochlorid | 762240-92-6 | Diabetes |
Vildagliptin | L-Prolinamid | 7531-52-4 | Diabetes |
Vildagliptin | (2S)-1-(Chloracetyl)-2-pyrrolidincarbonitril | 207557-35-5 | Diabetes |
Empagliflozin | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolacton | 32384-65-9 | Diabetes |
Vildagliptin | L-Prolinamid | 7531-52-4 | Diabetes |